If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Download FREE Excerpt
12 Info Graphics
39 Data Graphics
42 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Biotech; Pharmaceutical; Medical; Manufacturing; Medical Device; Health Care; Diagnostic; Biopharmaceutical; Clinical Research; Laboratories; Consumer Products; Chemical
Amgen; Alameda County Medical Center; Insight Adhesives Research; Siemens Medical; Nypro; GlaxoSmithKline; Abbott; UCB Pharma; Genzyme; Shire; Fibrogen; Terumo Corporation; Sanofi; Merck; Ipsen; Amylin; Lilly; Boehringer Ingelheim; Boston Scientific; Bayer Healthcare; Johnson & Johnson; Genentech; EMD Serono; Ben Venue Laboratories; Janssen; Smith & Nephew; Grifols; MedImmune
The report is based on the insights of 33 Business Continuity leaders from 29 national and global healthcare organizations. In addition, selected executives provided qualitative insights through deep-dive interviews and “lessons learned” observations.
Sample Key Findings
Emergency Response Training Is Essential For Fast Response – But Training Occurs Sporadically at Most Companies: More than 60% of companies conduct emergency response training once or twice a year – or not at all. Training frequency goes hand and hand with response effective-ness. This seems an Achilles’ heel for many companies. Less than 1/3 of companies train monthly or quarterly.
During Major Events: Communicate Early & Often: Active communication is a critical tool for managing through crisis. Daily briefings are advocated by 86% of the benchmark class and sharing of lessons learned is used by 71% of companies.
The Supply Chain Can Be Disrupted in Many (Unexpected) Ways: Natural disasters are not the only threat to a company’s supply of medical products to the market and its customers. Disruptions range widely from parts to material purity to manufacturing. Small disruptions can disrupt or shut down supply chains.